Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Jazz Pharmaceuticals (JAZZ)
NASDAQ:JAZZ
Jazz Pharmaceuticals (JAZZ) Stock Price & Analysis
1,006 Followers
JAZZ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$125.35 - $163.31
Previous Close$128.91
Volume501.09K
Average Volume (3M)495.85K
Market Cap
$8.30B
Enterprise Value$12.94B
Total Cash (Recent Filing)$1.17B
Total Debt (Recent Filing)$5.80B
Price to Earnings (P/E)-48.8
Beta0.52
Next Earnings
Aug 08, 2023EPS Estimate
$4.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.64
Shares Outstanding64,004,791
10 Day Avg. Volume704,783
30 Day Avg. Volume495,846
Standard Deviation0.09
R-Squared0.20
Alpha-0.00705
Financial Highlights & Ratios
Price to Book (P/B)-1.87
Price to Sales (P/S)9.24
Price to Cash Flow (P/CF)6.00
P/FCF Ratio5.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.46
Enterprise Value/Gross Profit4.15
Enterprise Value/Ebitda23.15
Forecast
1Y Price Target
$204.00Price Target Upside58.73% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Jazz Pharmaceuticals News
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
JAZZ FAQ
What was Jazz Pharmaceuticals’s price range in the past 12 months?
Jazz Pharmaceuticals lowest stock price was $125.35 and its highest was $163.31 in the past 12 months.
What is Jazz Pharmaceuticals’s market cap?
Currently, no data Available
When is Jazz Pharmaceuticals’s upcoming earnings report date?
Jazz Pharmaceuticals’s upcoming earnings report date is Aug 08, 2023 which is in 61 days.
How were Jazz Pharmaceuticals’s earnings last quarter?
Jazz Pharmaceuticals released its earnings results on May 10, 2023. The company reported $3.95 earnings per share for the quarter, missing the consensus estimate of $4.24 by -$0.29.
Is Jazz Pharmaceuticals overvalued?
According to Wall Street analysts Jazz Pharmaceuticals’s price is currently Undervalued.
Does Jazz Pharmaceuticals pay dividends?
Jazz Pharmaceuticals does not currently pay dividends.
What is Jazz Pharmaceuticals’s EPS estimate?
Jazz Pharmaceuticals’s EPS estimate is $4.5.
How many shares outstanding does Jazz Pharmaceuticals have?
Jazz Pharmaceuticals has 64,004,790 shares outstanding.
What happened to Jazz Pharmaceuticals’s price movement after its last earnings report?
Jazz Pharmaceuticals reported an EPS of $3.95 in its last earnings report, missing expectations of $4.24. Following the earnings report the stock price went up 0.41%.
Which hedge fund is a major shareholder of Jazz Pharmaceuticals?
Among the largest hedge funds holding Jazz Pharmaceuticals’s share is Polaris Capital Management LLC. It holds Jazz Pharmaceuticals’s shares valued at 191M.
---
Jazz Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$204.00 (58.73% Upside)
$204.00 (58.73% Upside)
Blogger Sentiment
Bullish
JAZZ Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 378.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $799.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.0%
Last 30 Days ▲ 5.0%
Last 30 Days ▲ 5.0%
News Sentiment
Positive
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.62%
12-Months-Change
Fundamentals
Return on Equity
-4.50%
Trailing 12-Months
Asset Growth
-6.13%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Jazz Pharmaceuticals
Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.
---
Top 5 ETFs holding JAZZ
Vanguard Health Care ETF
$30.87M
Amundi Index MSCI USA SRI PAB -UCITS ETF DR C- Capitalisation
$13.24M
iShares U.S. Pharmaceuticals ETF
$11.95M
VanEck Pharmaceutical ETF
$8.91M
iShares Core S&P Total U.S. Stock Market ETF
$8.46M
Up to five ETFs with an Outperform Smart Score that hold JAZZ. The ETFs are listed according to market value of JAZZ within the ETF
---
---